baber/WOPTO huggingface dataset:
Patent CA-2629744-A1 (CA)
Title: Viscoelastic cationic carbohydrate ether compositions
Inventor: KNOX PAUL W
IPC: C09K23/00
Filed: 2006-11-14
Abstract: A viscoelastic composition containing an effective amount of at least one cationic carbohydrate ether having one or more cationic fragments and one or more carbohydrate fragments connected through one or more linker fragments for controlling the viscoelasticity of the composition, wherein at least some carbohydrate fragments are connected to the linker fragments through ether bonds.
Patent CA-2630392-A1 (CA)
Inventor: HOLLANDER ELCO DICK
IPC: B01D21/24
Filed: 2008-05-05
Abstract: There is provided a method of determining settling rate of a settling component which is derived, at least in part, from a hydrocarbonaceous slurry. The method includes admixing a hydrocarbonaceous slurry and a solvent to produce an admixture. The hydrocarbonaceous slurry includes a hydrocarbon component, water and solid particulate material. The admixture is flowed to a settling tank, and thereby effecting filling of the settling tank with the admixture.  The flow of the admixture to the settling tank is ceased upon filling of the settling tank with the admixture to a predetermined level. After the flow of the admixture has ceased, a settling rate of a settling component is measured as the settling component moves downwardly within the settling tank.
Patent CA-2631476-A1 (CA)
Inventor: CHOU WA LOK
IPC: G01N33/552
Filed: 2005-12-12
Abstract: The invention encompasses microfluidic microarray assemblies (MMA) and subassemblies and methods for their manufacture and use. In one embodiment, first and second channel plates are provided and are sealingly connected to a test chip in consecutive steps. Each plate includes microfluidic channels configured in a predetermined reagent distribution pattern. The test chip comprises a plurality of discrete test positions, each test position being located at the intersection between a first predetermined reagent pattern and a second predetermined reagent pattern, wherein at least one of said patterns is non-linear. The first channel plate allows the distribution of a first reagent on said test chip, wherein said first reagent is immobilized at said test positions. The second channel plate allows the distribution of a second reagent on said test chip, wherein said second reagent comprises a plurality of different test samples.
Patent CA-2631772-A1 (CA)
Title: System, method and computer program product for dynamically enhancing an application executing on a computing device
Inventor: SHEORY OHAD
IPC: G06Q30/00
Filed: 2006-11-28
Abstract: A system, method and computer program product for dynamically enhancing a software application, such as a video game, executing on a computing device, without having to change and recompile the original application code. The system includes a staging environment that monitors the execution of the application and indexes each item of graphical and/or audio information generated by the application into a first database. A system administrator or other entity then populates a second database by manual or automated means with one or more business rules, wherein each business rule is associated with one or more of the objects indexed in the first database. The system further includes a run-time environment that identifies items of of graphics and/or audio information as they are generated by the application during run-time, uses the second database to determine if an identified item is associated with a business rule, and, responsive to a determination that an identified item is associated with a business rule, applies the business rule.
Patent CA-2638819-A1 (CA)
Title: Soluble il-17rcx4 and methods of using in inflammation
Inventor: LEVIN STEVEN D
IPC: C07K16/28
Filed: 2007-02-09
Abstract: The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17F, IL-17A, or both IL-17A and IL-17F polypeptide molecules. IL-17A and IL-17F are cytokines that are involved in inflammatory processes and human disease. IL-17RC is a common receptor for IL-17A and IL-17F. The present invention includes methods of using a soluble IL-17RC receptor, IL-17RCx4 for treating inflammation.
Patent CA-2640526-A1 (CA)
Title: Resol beads, methods of making them, and methods of using them
Inventor: FAUVER JERRY STEVEN
IPC: C08G8/10
Filed: 2007-02-05
Abstract: Resol beads are disclosed, having a relatively narrow size distribution, prepared in high yield by reaction of a phenol with an aldehyde, with a base as catalyst, in the presence of previously-formed resol beads, a colloidal stabilizer, and optionally a surfactant. The resol beads may be thermally treated to prevent sticking and clumping and have a variety of uses, such as in the formation of activated carbon beads.
Patent CA-2641168-A1 (CA)
Title: Novel fabrication process for thermoplastic composite parts
Inventor: FOX JAMES R
IPC: B29C70/30
Filed: 2007-02-02
Abstract: A fabrication method of forming a thermoplastic composite laminate material with tailored and varying thickness in a continuous process. This process utilizes automated equipment or hand lay-up to collate parts or components into a multi-layer stack. Each stack contains all plies, including ply build-up areas, tacked in the proper location to maintain orientation and location. The consolidation tooling contains all necessary part features and is coordinated to the customized multiple ply stacks to form a single integrated thermoplastic composite laminate potentially having areas of differing thickness from these multiple ply stacks.
Patent CA-2645079-A1 (CA)
Title: Use of lipid conjugates for the coating of stents and catheters
Inventor: YEDGAR SAUL
IPC: A61F2/28
Filed: 2007-03-11
Abstract: This invention provides inter alia, coated device on at least a portion of a surface of the device. The device coating comprises a lipid or phospholipid moiety bound to a polypyranose. Methods of preventing, inhibiting or treating vessel damage or vessel occlusion, for example in a disease of the vasculature in a subject such as cardiovascular or cerbrovascular disease are described.
Patent CA-2645961-A1 (CA)
Inventor: RINALDI-CARMONA MURIELLE
IPC: C07D405/12
Filed: 2007-04-12
Abstract: La présente invention a pour objet des composés répondant à la formule : (I) dans laquelle : Z représente un groupe N(R3)XR4, N(R3)COOR5 ou OCON(R3)R5; X représente un groupe -CO-, -SO2-, -CON(R6)- ou CSN(R6)-; - R1 et R2 représentent chacun indépendamment l'un de l'autre un atome d'hydrogène ou un (C1-C7)alkyle ou ensemble avec l'atome d'azote auquel ils sont liés constituent un radical hétérocyclique saturé ou insaturé; R3 et Rg représente un atome d'hydrogène ou un groupe (C1-C4)alkyle; - R4 représente :. un groupe (C3-C10)alkyle \ un radical carbocyclique; un radical hétérocyclique; un indolyle; un tétrahydronaphtalényle, un naphtalényle; un benzothiophényle ou un benzoruryle; un phényle; un benzodioxyle; un phénoxyméthylène, un 1-phénoxyéthylène; un phénylcyclopropyle; R5 représente un phényle; A1 et Ar2 représentent chacun indépendamment l'un de l'autre un phényle non substitué ou substitué; n représente 0, 1 ou 2; AIk représente un groupe (C1-C7)alkyle; à l'état de base ou de sel d'addition, ainsi qu'à l'état d'hydrate ou de solvat.
Patent CA-2646441-A1 (CA)
Title: Device for pasteurizing a mass of foodstuff
Inventor: SCHUTEN HENRICUS JOHANNES
IPC: A23L5/10
Filed: 2007-03-17
Abstract: A device for pasteurizing a mass of foodstuff comprises: a feed; at least one first tube, connecting to the feed, of an electrically and magnetically inert material suitable for contact with food; two plate-like electrodes which are situated on either side of the first tube and which are connected to an RF power generator, whereby the mass present in the first tube is heated dielectrically in this first tube; a first jacket filled with a heatable first liquid and extending around the first tube; and heating means which connect to the first tube and in which the hot mass is held at practically constant temperature; at the end of which heating means the hot mass is discharged for further processing, such as cooling, portioning and packaging.
Patent CA-2647448-A1 (CA)
Title: Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
Inventor: BARBER CHRISTOPHER GORDON
IPC: C07D413/14
Filed: 2007-03-30
Abstract: The present invention provides compounds of formula (I) wherein R1 to R6 and m are as defined hereinabove. The compounds of the present invention are modulators, especially antagonists, of the activity of chemokine CCR5 receptors. Modulators of the CCR5 receptor may be useful in the treatment of various inflammatory diseases, autoimmune diseases, pain, and. in the treatment of infection by HIV and genetically related retroviruses.
Patent CA-2647902-A1 (CA)
Title: Processes for preparing ezetimibe and intermediate compounds useful for the preparation thereof
Inventor: NETTEKOVEN ULRIKE
IPC: C07D205/08
Filed: 2007-03-29
Abstract: The invention relates, in general, to an improved process for converting compounds of Formula II (below) to compounds of Formula III (below), which are key intermediates for the synthesis of ezetimibe, or to ezetimibe itself, wherein in Formulas II and III, R represents hydrogen, alkyl, or a hydroxyl protecting group (e.g., benzyl group, a substituted benzyl group, or a silyl group). The invention further includes the use of the described process and the use of compounds of Formula III made by the described process for the preparation of ezetimibe.
Patent CA-2649614-A1 (CA)
Inventor: KANG SANG OOK
IPC: C08F4/649
Filed: 2007-04-24
Abstract: The present invention relates to a bis-arylaryloxy catalyst system for the production of ethylene homopolymers or copolymers with .alpha.-olefins, which has high catalytic activity. More particularly, it relates to a transition metal catalyst comprising a group-IV transition metal as a central metal, a cyclopentadiene derivative around the central metal, and two aryloxide ligands substituted with aryl derivatives at the ortho-positions, the ligands not being bridged to each other, as well as a catalyst system comprising said catalyst and an aluminoxane co-catalyst or a boron compound co-catalyst, and a method for producing high-molecular-weight ethylene homopolymers or copolymers with .alpha.-olefins using the same.
Patent CA-2650146-A1 (CA)
Inventor: KHAYAT MARIO
IPC: A61B5/00
Filed: 2009-01-16
Abstract: The present invention relates to a method of decomposition of a test sample into constituents thereof. The method proceeds by optically imaging the test sample to obtain a corresponding unknown time-domain resolved signal and decomposes the unknown time-domain resolved signal by comparing the unknown time-domain resolved signal with time-domain resolved reference signals. Furthermore, the method allows the determination of the presence or absence of constituents. Relative quantities may also be determined if sample material properties are known or taken into account.  Lifetime decay of the constituents may also be estimated by handling effect of light diffusion in the test sample as time decay.
Patent CA-2650773-A1 (CA)
Inventor: HU ZHIHAO
IPC: C12N9/10
Filed: 2007-05-18
Abstract: Genetically engineered microorganisms are provided that produce products from the fatty acid biosynthetic pathway (fatty acid derivatives), as well as methods of their use.
Patent CA-2651296-A1 (CA)
Inventor: NICOLAS JEAN-PIERRE
IPC: A61K36/81
Filed: 2007-05-09
Abstract: The invention relates to the use of an aqueous tobacco leaf extract for the preparation of a medicinal product for the treatment of dependence, particularly tobacco dependence, and to a sterile injection solution and a kit usable for the treatment of dependence, particularly of tobacco.
Patent CA-2655577-A1 (CA)
Title: Hydraulic metering valve for operation of downhole tools
Inventor: KIMPEL ROBERT P
IPC: E21B41/00
Filed: 2007-06-27
Abstract: Methods and systems for operating a sliding sleeve valve or other downhole well tool (14) that is axially shiftable among a finite number of increments between two extreme configurations such as open and closed configurations. A metering device is described having a pair of piston metering assemblies (36, 38) that operate in parallel fluid flow paths. The first piston metering assembly (36) moves the sleeve of the well tool from a fully closed position to the zero position. The second piston metering assembly can be repeatedly pressurized and depressurized to meter predetermined amounts of fluid from an actuator sequentially to move the sleeve of the sleeve valve in consecutive increments toward a fully open position.
Patent CA-2655649-A1 (CA)
Inventor: DELAINE PATRICK
IPC: F24H3/08
Filed: 2007-06-18
Abstract: The subject of the invention is a hot gas generator (8), particularly for a dehydration or drying unit, the generator comprising a burner or hearth (9) and being characterized in that it comprises at least one exchange circuit (10) comprising at least one pipe through which the gas to be heated flows, the pipe comprising a cool gas inlet end (11) and a hot gas discharge outlet (12), the pipe having a surface for heat exchange between the combustion gases generated by the burner or hearth (9) and the gas to be heated which flows through the pipe, the pipe also providing a physical barrier between the heated gases and the combustion gases generated by the burner or hearth. Application to producing a drying or dehydration installation.
Patent CA-2655882-A1 (CA)
Title: Tfla gene which can degrade toxoflavin and its chemical derivatives and transgenic organisms expressing tfla gene
Inventor: JWA NAM SOO
IPC: C12N15/82
Filed: 2007-06-21
Abstract: The present invention relates to a microorganism which can degrade toxoflavin and its derivatives, a protein which can degrade toxoflavin and its derivatives, a use of said protein as a selection marker for plant transformation, a gene which encodes said protein, a recombinant expression vector comprising said gene, a transgenic organism which is transformed with said vector, an expression cassette of a selection marker comprising tflA gene for plant transformation, a recombinant vector comprising said expression cassette, a plant which is transformed with said vector, a method of selecting transgenic plants using tflA gene, and a method of preparing transgenic plants using tflA gene. According to the present invention, transgenic plants which express tflA are given with the resistant character to toxoflavin. Particularly for rice cultivation, more grains can be harvested and quality of grains can be improved, thanks to a resistance to bacterial grain rot. In addition, instead of using expensive antibiotics, transgenic plants can be easily selected by using rather cheap toxoflavin.
Patent CA-2656273-A1 (CA)
Inventor: SHAMSUDDIN ABULKALAM M
IPC: A01N57/00
Filed: 2007-06-15
Abstract: Inositol hexaphosphate (IP-6) is a polyphosphorylated carbohydrate with potent antioxidant activity to prevent active oxygen species-mediated mutagenesis, cell injury and carcinogenesis IP-6 also activates DNA repair mechanisms Sublethal radiation causes DNA 5 damage through the fonnation of free radicals, reactive oxygen species, and pyrimidine crosslinks leading to cellular proliferation, cell cycle arrest and apoptosis IP-6 and/or inositol and their pharmaceutically acceptable salts and de.pi.vatives, including pyrophosphates and citrate derivatives, significantly counteract the harmful effects of radiation, affecting cell cycle progression in a protective manner (more cells in the protective Gl phase) as well as decreasing apoptosis and caspase-3 activation Vanous salts of IP-6 are used with 15 comparable efficacy and the combination of IP-6 + inositol affords the best protection against radiation-induced cell injury Thus IP-6 and inositol are effective agents for protection against nuclear, solar and other radiation injuries.
Patent CA-2657001-A1 (CA)
Inventor: BRANSON MARK
IPC: B65D33/16
Filed: 2007-04-11
Abstract: A fastener strip, such as would be used in a reclosable container, comprises a sealing member having a plurality of sealing portions configured to engage complementary sealing portions of a complementary fastener strip. At least one sealing portion comprises one or more finger members extending therefrom. The at least one finger member, by engaging a complementary sealing portion of a complementary fastener strip, provides an additional degree of sealing, particularly when the fastener strips are in a partially engaged condition. A slider comprises top and side walls and inwardly facing flanges, preferably at lower ends of the side walls. The inwardly facing flanges define a gap having dimensions such that the sealing members of the opposing fastener strips, and particularly the sealing portion having the at least one finger member and its complementary sealing portion, are urged together to provide an additional degree of sealing, yet not completely interlocking, engagement.
Patent CA-2657507-A1 (CA)
Inventor: MUEHLNER MARCO
IPC: H01M8/02
Filed: 2007-05-23
Abstract: The invention relates to an apparatus (12 to 26) for supplying media to a fuel cell arrangement (28) in a fuel cell system (10), which apparatus at least partially consists of a chromium-containing metal alloy. According to the invention, a surface (30) of the apparatus coming into contact with supply media is at least partially coated with a metal oxide ceramic (32).
Patent CA-2657851-A1 (CA)
Title: System to control the trim of motorcycles with three or four wheels
Inventor: MARABESE LUCIANO
IPC: B62K5/027
Filed: 2006-07-28
Abstract: It is described a system to control the trim of motorcycles with three or four wheels, including for each couple of wheels a system of levers (1) linking the hubs of the wheels v(7, 8) belonging to the couple, a shock absorber and one or more dampers (5) directly installed between said wheels v(7,8), or between said system of levers v(1) and a fixed point v(51) on the vehicle frame or chassis.
Patent CA-2658393-A1 (CA)
Inventor: JONES R BRADLEY
IPC: A61K38/00
Filed: 2007-07-19
Abstract: The present invention provides isolated HERV polypeptides; and compositions, including immunogenic compositions, comprising a HERV polypeptide. The present invention provides immunogenic compositions comprising a nucleic acid comprising a nucleotide sequence encoding a HERV polypeptide. The immunogenic compositions are useful for stimulating a T cell immune response to a lentiviral peptide. The present invention further provides methods of stimulating an immune response in an individual to a retrovirus- or lentivirus-infected cell. The present invention further provides methods of treating cancers in which HERV polypeptides are expressed. Also provided are methods of treating disorders, involving decreasing an immune response to a HERV polypeptide.
Patent CA-2660197-A1 (CA)
Title: Pyrrolo[3,2-d]pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus
Inventor: HIMMELSBACH FRANK
IPC: C07D487/04
Filed: 2007-08-07
Abstract: The present invention relates to substituted pyrrolo[3,2-d]pyrimidines of formula (I), wherein R1 and R2 are defined as in claim 1, including the tautomers, stereoisomers, mixtures and salts thereof, which have valuable pharmacological properties, particularly an inhibitory effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
Patent CA-2661601-A1 (CA)
Inventor: KISS GUENTER H
IPC: C10J3/66
Filed: 2007-08-24
Abstract: The invention relates to a method for disposal and reclamation of waste materials of all types, wherein the waste materials are compressed in batches into compact packages and run through temperature treatment zones, to give synthesis gas and the synthesis gas is transformed in a further reaction to give hydrocarbon molecules.
Patent CA-2662733-A1 (CA)
Title: Coupling-enhanced surface etched gratings
Inventor: PIMENOV KIRILL
IPC: G02B5/26
Filed: 2007-09-12
Abstract: The invention describes the method and apparatus for enhancement of coupling efficiency in effective-ridge laterally-coupled surface-etched grating waveguide structures, where a slab waveguide has a sequence of the periodic parallel segmented trenches etched from its top surface, such that the segments of intact material having higher refractive index than that in the surrounding segments of periodic trenches form the effective ridges which confine the optical field in and around these ridges, on one hand, and provide bidirectional coupling for the confined modes experiencing Bragg reflection from the segments of the periodic trenches, on the other. The invention discloses the designs of the multiple effective ridge laterally coupled surface-etched grating waveguide structures, which enhances the coupling efficiency as compared to a conventional single effective ridge grating design because of an intended dilution of the lateral confinement caused by the multiple effective ridges, resulting in an increase of the optical mode's overlap with the surface etched grating formed everywhere outside the effective ridges.
Patent CA-2662738-A1 (CA)
Inventor: ZHAI SUPING
IPC: H04L12/42
Filed: 2007-06-28
Abstract: A method for avoiding data to cycle in loop in a ring ethernet. The method includes steps: the transfer node in the ring net detects the failure and then prohibits the user data message transferability of the port in the link which is affected by the failure; the main node accomplishs protection switching after acquiring the ring net failure; the transfer node updates its transfer list and transfers messages according to the updated transfer list; if the failure is eliminated, the main node enters the proper working state, and the transfer node enables the user data message transferability of the port in the link which is affected by the failure. A apparatus and system for avoiding data to cycle in loop in a ring ethernet are also proposed. The probability of data-cycling-in-loop can be effectively decreased or even be entirely avoided.
Patent CA-2662862-A1 (CA)
Title: Treatment of aplastic anemia
Inventor: MOORE MARGARET D
IPC: A61K39/00
Filed: 2007-08-27
Abstract: Methods of treating aplastic anemia in a patient and of increasing blood cell production in a patient having aplastic anemia are disclosed. The methods comprise administering to the patient a therapeutically effective amount of an IL-27 antagonist in combination with a pharmaceutically acceptable vehicle. IL-27 antagonists include soluble IL-27RA proteins and antagonists that comprise an antigen-binding site of an antibody.
Patent CA-2663029-A1 (CA)
Title: Targeted whole genome amplification method for identification of pathogens
Inventor: ECKER DAVID J
IPC: C12Q1/68
Filed: 2007-09-14
Abstract: The methods disclosed herein relate to methods and compositions for amplifying nucleic acid sequences, more specifically, from nucleic acid sequences of pathogens by targeted whole genome amplification.
Patent CA-2663458-A1 (CA)
Inventor: LEWANDOWSKI MARK A
IPC: C09J7/29
Filed: 2007-09-24
Abstract: A pressure-sensitive tape comprising a backing, a layer of corrosion-resistant filaments on one surface of the backing, and pressure-sensitive adhesive layer that coats the filaments and binds them to the backing. A method for constructing a member for undersea deployment is provided, which comprises providing at least one tubular member, winding a wire reinforcement about the tubular member(s); and winding a corrosion- resistant filament-reinforced material over the wire reinforcement; and coating the filament reinforced member(s) with a layer of extruded polymer.